Home›Stock Screener›Indrayani Biotech›Quarterly Results

Indrayani Biotech Quarterly Results

Latest Quarter Net Profit
₹1 Cr
QMar 2026
Quarterly Results

Indrayani Biotech quarterly results. In Mar 2026, Indrayani Biotech (INDRANIB) reported revenue ₹39 Cr and net profit ₹1 Cr — revenue -26.4% YoY. For annual financials, live price and key ratios, visit Indrayani Biotech share price chart.

INDRANIB Quarterly Results — Revenue, Profit & EPS Highlights

Indrayani Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore INDRANIB stock price history to track price trends across different timeframes.

  • Revenue of ₹39 Cr in Mar 2026 (+0.0% vs Jun 2026, -26.4% vs Mar 2025)
  • Net Profit of ₹1 Cr in Mar 2026 (+0.0% vs Jun 2026, +111.1% vs Mar 2025)
  • EBITDA of ₹3 Cr in Mar 2026 (+0.0% vs Jun 2026)
  • Operating Margin of 6.0% in Mar 2026 (+2.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.24 in Mar 2026 (+300.0% vs Jun 2026)

Indrayani Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

INDRANIB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 39 39 38 53 30 - -26.4%
Net Profit (₹ Cr) 1 1 1 -9 0 - -
EBITDA (₹ Cr) 3 3 4 -3 3 - -
EPS (₹) 0.24 0.06 0.09 -1.88 0.03 - -
Operating Margin (%) 6.0% 4.0% 7.0% -11.0% 7.0% - -

INDRANIB Share Price Trend — 1-Year Movement Across Quarterly Results

Indrayani Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View INDRANIB price range for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 2.6%
EBITDA Margin 7.7%
Operating Margin 6.0%
ROE (Annual) 5.5%

Balance Sheet Highlights

Total Assets ₹253 Cr
Total Equity ₹73 Cr
Current Assets ₹ Cr
Current Liabilities ₹58 Cr

Cash Flow Analysis

Operating Cash Flow ₹-7 Cr
Investing Cash Flow ₹25 Cr
Financing Cash Flow ₹-18 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹8.86
Exchange BSE
Last Updated Nov 20, 2026

INDRANIB vs FMCG Peers — Quarterly Revenue, Profit & Market Cap

Indrayani Biotech latest quarter revenue and net profit vs FMCG competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Hindustan Unilever
Sept 2026
₹468,273.54 Cr 2052.5 18,233 2,796 +9.1% - 15.3% 172.9
ITC
Sept 2026
₹371,655.14 Cr 299.1 20,726 4,229 +12.9% - 20.4% 90.1
Nestle
Sept 2026
₹255,501.65 Cr 1325.0 6,802 1,010 +0.9% - 14.8% 252.9
Varun Beverages
Sept 2026
₹145,684.04 Cr 427.5 6,727 831 +1.6% - 12.4% 174.5
Marico
Sept 2026
₹118,791.72 Cr 917.0 3,950 558 +17.5% - 14.1% 216.3
Sector Quarterly Performance Comparison
FMCG sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores